KALA BIO, Inc.
Arlington, United States
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
KALA BIO, Inc was founded by Avi Minkowitz, Charles B. McDermott, Kevin Bitterman, Robert Tepper, Robert Paull, Kim Brazzell, Howard B. Rosen, Karen Wagner, Mark Iwicki, Rajeev B. Shah, Robert Langer, Hongming B. Chen, Chen B. Yu, Greg Grunberg, Gregory D. Perry, Mary Reumuth, Mark S. Blumenkranz, Andrew L. Koven, Darius Daniel Kharabi, Gregory D. Grunberg, Hongming Chen, Robert D. Paull, Eric L. Trachtenberg, C. Daniel Myers, Todd Bazemore, Marjan D. Farid, Darius Kharabi, Andrew I. Koven, Yonatan Colman, Brendan Purdy, Chaim Berger, Hillel Posen and David Lazar, and is based in Arlington, United States.
Key facts
- Industry
- Pharmaceuticals
- Legal form
- Incorporated in Delaware
- Listed
- Nasdaq · KALA
About
Pharmaceutical Preparations; listed on Nasdaq as KALA; filing with the SEC since 2009
Founders
Executive Officer, Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
In context
We hold 687 other pharmaceuticals companies. None has a closure on record yet. Of the 638 that report what they raised, the median is $4,127,748.
Counted across this directory, from founding and closing years in public records. Medians cover only companies whose closure is recorded; a company with no closure date may have quietly ceased without the record catching it.
Discussion
Log in to join the discussion and like comments.
Log In to Comment